NeurAxis, Inc. (NRXS )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol NRXS
- Company NeurAxis, Inc.
- Price $2.42
- Changes Percentage 23.94
- Change 0.4668
- Day Low $2.01
- Day High $2.53
- Year High $3.78
- Year Low $1.33
- Market Cap $17,439,290
- Price Avg 50 EMA (D) $2.1
- Price Avg 200 EMA (D) $2.68
- Exchange NASDAQ
- Volume 68,389
- Average Volume 26,811
- Open $2.01
- Previous Close $1.95
- EPS -1.22
- PE -1.98
- Earnings Announcement 2025-05-19 04:00:00
- Shares Outstanding $7,215,860
Company brief: NEURAXIS, INC. (NRXS )
- Healthcare
- Biotechnology
- Mr. Brian Carrico
- https://neuraxis.com
- US
- N/A
- 08-09-2023
- US64134X2018
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.